{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001050",
    "licUnit": "1",
    "validDate": "2027-07-17 00:00:00.000",
    "issueDate": "2017-07-17 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000105002",
    "prodNameC": "癌自禦 注射劑",
    "prodNameE": "Tecentriq",
    "indicationsName": [
        "１、非小細胞肺癌：\n(１)單獨使用，適用於第II至IIIA期(UICC\/AJCC分期系統第7版)且腫瘤具PD-L1表現(tumor cell (TC) ≥ 1%)之非小細胞肺癌病人接受手術切除及含鉑藥物化學治療後的輔助性治療。\n(２)單獨使用，適用於治療接受含鉑化學治療後，疾病惡化之局部晚期或轉移性非小細胞肺癌病人。病人若具有EGFR或ALK腫瘤基因異常，則須先經EGFR或ALK抑制劑治療，若治療後疾病惡化方可使用本品。\n(３)與bevacizumab、paclitaxel和carboplatin併用，做為轉移性之非鱗狀非小細胞肺癌的第一線治療藥物。病人若具有 EGFR 突變或 ALK 呈陽性者，則須先經適當的標靶藥物治療，若治療後疾病惡化方可與bevacizumab、paclitaxel 和carboplatin併用治療。\n(４)與nab-paclitaxel carboplatin併用，做為轉移性，不具EGFR或ALK腫瘤基因異常之非鱗狀非小細胞肺癌的第一線治療。\n(５)單獨使用，適用於第一線治療成人之轉移性、不具有EGFR或ALK腫瘤基因異常，且腫瘤具PD-L1高表現(tumor cells (TC) ≥ 50%或tumor infiltrating immune cells (IC) ≥10%)之非小細胞肺癌。\n(６)單獨使用，適用於第一線治療不具有EGFR 或ALK 腫瘤基因異常，且不適合含鉑化學治療之局部晚期或轉移性非小細胞肺癌成人病人。\n\n２、三陰性乳癌：與nab-paclitaxel併用，適用於治療無法切除之局部晚期或轉移性三陰性乳癌，且腫瘤具PD-L1表現(tumor-infiltrating immune cells (IC) ≥ 1%)且未曾接受化療用於轉移性乳癌之病人。\n３、小細胞肺癌：與carboplatin 和etoposide 併用，適用於第一線治療成人擴散期小細胞肺癌(extensive stage small cell lung cancer)。\n４、肝細胞癌：與bevacizumab併用，適用於治療未曾接受全身性療法且無法切除或轉移之肝細胞癌病人，且肝功能為Child-Pugh A。"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "",
            "packageUnit": "L2"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "99C31A0E-D601-4BF8-A04B-24463C2EB0C0",
    "subCategory": [],
    "ingredientsDesc": [
        "Atezolizumab"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1S",
        "5F"
    ],
    "applicantName": "羅氏大藥廠股份有限公司",
    "applicantAddr": "台北市南港區經貿一路170號10樓、10樓之1至之3、10樓之5至之8",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2022-07-17",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "C7829361-466D-499A-9EAA-B94C94358A07",
            "factoryCode": "1",
            "factoryName": "F. HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "66",
                    "name": "成品製造廠"
                }
            ],
            "processCodeStr": "66;成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FCH0257000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "0494D7BB-BA6C-4F8D-9CA2-17F0D9017A80",
            "factoryCode": "1",
            "factoryName": "ROCHE DIAGNOSTICS GMBH",
            "factoryAddr": "SANDHOFER STRASSE 116, 68305 MANNHEIM, GERMANY",
            "factoryCompanyAddr": null,
            "countryCode": "DE",
            "processCode": [
                {
                    "value": "66",
                    "name": "成品製造廠"
                }
            ],
            "processCodeStr": "66;成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FDE0261000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "850BCBBD-C089-4470-8820-AD99B6B4EE0C",
            "factoryCode": "2",
            "factoryName": "F.HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "GRENZACHERSTRASSE 124, CH-4070 BASEL,SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "65",
                    "name": "主成分(drug substance)製造廠"
                }
            ],
            "processCodeStr": "65;主成分(drug substance)製造廠",
            "factoryKind": "M",
            "factoryNo": "FCH0093000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "58E806DF-C36F-4E9B-9BA0-12CB1DA50806",
            "factoryCode": "2",
            "factoryName": "F.HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "FCH0208000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013001500",
            "ingredientsName": "Atezolizumab",
            "ingredientsDesc": "Atezolizumab",
            "concentDesc": "",
            "concent": "60.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01FF05"
        }
    ],
    "licBaseId": "3D1A7225-45D7-47FB-9F95-4D8B83E68DFD"
}